# Xerostomia in Head and Neck Cancer Patients Receiving Radiation as the Primary Treatment Versus Patients Who Will Not Have Such a Procedure

> **NCT00168116** · PHASE2 · COMPLETED · sponsor: **AHS Cancer Control Alberta** · enrollment: 42 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **PROCEDURE:** radiation treatment and surgery
- **PROCEDURE:** radiation alone

## Key facts

- **NCT ID:** NCT00168116
- **Lead sponsor:** AHS Cancer Control Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-07
- **Primary completion:** 2009-05
- **Final completion:** 2009-06
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2016-02-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00168116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00168116, "Xerostomia in Head and Neck Cancer Patients Receiving Radiation as the Primary Treatment Versus Patients Who Will Not Have Such a Procedure". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT00168116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*